Coenzyme Q10 and oxidative stress, the association with peripheral sensory neuropathy and cardiovascular disease in type 2 diabetes mellitus
- 1 November 2015
- journal article
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 29 (8) , 1152-1158
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Markers of innate immune activity in patients with type 1 and type 2 diabetes mellitus and the effect of the anti-oxidant coenzyme Q10 on inflammatory activityClinical and Experimental Immunology, 2014
- Diabetic neuropathy: clinical manifestations and current treatmentsThe Lancet Neurology, 2012
- Plasma coenzyme Q10 is increased during gestational diabetesDiabetes Research and Clinical Practice, 2011
- Effect of Coenzyme Q10 on Myopathic Symptoms in Patients Treated With StatinsThe American Journal of Cardiology, 2007
- Coenzyme Q10 affects expression of genes involved in cell signalling, metabolism and transport in human CaCo-2 cellsThe International Journal of Biochemistry & Cell Biology, 2005
- The Pathobiology of Diabetic ComplicationsDiabetes, 2005
- Diabetes and AtherosclerosisJAMA, 2002
- Biochemistry and molecular cell biology of diabetic complicationsNature, 2001
- The effect of coenzyme Q10 on blood glucose and insulin requirement in patients with insulin dependent dlabetes mellitusMolecular Aspects of Medicine, 1997
- The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohortNeurology, 1993